These high-risk haplotypes are thought to confer diabetes risk through different amino acid residues in the MHC peptide binding pocket which alters both the register in which peptides bind to MHC and the binding affinity of the MHC:peptide complex when presented to T cells. Here, HLA-C is linked to diabetes mellitus.